ClinicalTrials.gg
Drug

Buparlisib clinical trials

Also written BKM120.

studies test it
79
open now
0
in phase 3
3
first study started
2008

How each study uses buparlisib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Buparlisib
28
PI3K inhibitor BKM120
7
PI3K_Inhibitor_BKM120
6
Buparlisib (BKM120)
3

Development codes

BKM120
63
AN2025
1

Studies by the year they started

79 studies that test it; most in 2012 (22)

Studies that test buparlisib, by start year
YearStudies
20081
20091
20103
201115
201222
201313
201416
20156
20161
20211

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
42
Phase 2
38
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 31 · Other 48

Novartis Pharmaceuticals (27) · Dana-Farber Cancer Institute (4) · Memorial Sloan Kettering Cancer Center (4) · SCRI Development Innovations, LLC (3) · Canadian Cancer Trials Group (2) · Roswell Park Cancer Institute (2) · Washington University School of Medicine (2) · L. Nicolas Gonzalez Castro, MD, PhD (1)

Often tested with

Tested in the same studies.

Alpelisib (3) · Dactolisib (3) · Binimetinib (2) · Sonidegib (2) · E7046 (1) · Encorafenib (1) · Ribociclib (1) · Infigratinib (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses buparlisib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 79

See all 79 studies that test buparlisib →

Given beside what is tested · 5 — buparlisib is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with buparlisib

Codes

What other systems call buparlisib · ClinicalTrials.gg INT006021

  • UNII (FDA) 0ZM2Z182GDBUPARLISIBConfirmed FDA, Wikidata
  • Wikidata Q25100534buparlisibConfirmed FDA, Wikidata
  • NCI Thesaurus C90565BuparlisibOne source FDA
  • DrugBank DB11666One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.